Botox 100 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FBSEB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,517
Award facts
- Contract value 100% obligated
- $11,516.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $11,516.88 to DMS Pharmaceutical Group Inc. for 100-unit vials of BOTOX, with an ultimate completion date of January 28, 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected under a firm fixed-price contract with no set-aside designation. The award represents a routine pharmaceutical procurement to support Department of Defense medical supply requirements.
This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) within the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy that establishes multiple regional prime vendor contractors. The underlying IDC, designated SPE2DR and valued at $499.999 billion with a completion date of December 31, 2036, authorizes the issuance of firm fixed-price delivery orders for comprehensive pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables to support military healthcare facilities worldwide. As a critical supplier within the federal pharmaceutical supply chain since 2001, DMS Pharmaceutical Group has demonstrated consistent performance across numerous delivery orders spanning diverse therapeutic categories and product lines.
Quick answers
Who was awarded contract SPE2DR26FBSEB?
SPE2DR26FBSEB was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FBSEB worth?
The government has obligated $11,517 on SPE2DR26FBSEB.
Is contract SPE2DR26FBSEB an order under another contract?
Yes. SPE2DR26FBSEB is a delivery order under SPE2DR25D9158, an indefinite delivery contract.
Was contract SPE2DR26FBSEB competed?
The extent of competition for SPE2DR26FBSEB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award